April 28, 2019, Sunday
The USFDA has classified both the recalls as a Class-II recall
March 30, 2019, Saturday
Sources revealed that the firms that got approval planned to launch the product in the US at the earliest
October 13, 2018, Saturday
The regulator has bettered last year's numbers with 971 approval actions this year
September 15, 2018, Saturday
Ajovy injection seen generating $500 million in sales by 2022
June 11, 2018, Monday
Apart from maufacturing herbal extracts and essential oils, the firm has also diversified into coffee production
January 11, 2018, Thursday
Indian pharma firms including their subsidiaries have received around 304 abbreviated new drug application approvals from the ...
August 03, 2017, Thursday
The tablets are indicated for treatment of adult patients with hypertriglyceridemia
July 12, 2017, Wednesday
The USFDA has issued a warning letter to the manufacturing facility of the city-based Vista Pharmaceuticals Ltd, for "significant ...
July 03, 2017, Monday
The product will be manufactured at a USFDA approved contract manufacturing organisation
May 01, 2017, Monday
This has led to rise in warnings too; 55% of GMP warnings since 2012 issued to Indian, Chinese cos
